- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01614678
A Comparison of Manufacturing Processes for AIR OPTIX® COLORS Contact Lens
May 3, 2017 updated by: CIBA VISION
AIR OPTIX® COLORS: Automated vs Semi-automated Manufacturing Processes
The purpose of this feasibility study was to compare AIR OPTIX® COLORS contact lenses manufactured using an automated process to AIR OPTIX® COLORS contact lenses manufactured using a semi-automatic process.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
49
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Able and willing to sign a written Informed Consent form.
- Cylinder ≤ -0.75 diopter (D).
- Able to achieve visual acuity (VA) of at least 20/30 Snellen in each eye at distance with contact lenses (CLCVA) and best corrected visual acuity (BCVA) ≥ 20/25.
- Have spectacles that provide acceptable vision and be willing to wear them if unable to wear the study lenses.
- Successful daily wear of single-vision spherical soft contact lenses in both eyes during the past 3 months for a minimum of 8 hours/day, 5 days/week.
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
- Eye injury or surgery within twelve weeks immediately prior to enrollment in this trial.
- Pre-existing ocular irritation that would preclude contact lens fitting.
- Currently enrolled in an ophthalmic clinical trial.
- Evidence of systemic or ocular abnormality, infection, or disease likely to affect successful wear of contact lenses or use of accessory solutions, as determined by the investigator.
- Pathologically dry eye.
- Other protocol-defined exclusion criteria may apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: AIR OPTIX® COLORS Auto, then AIR OPTIX® COLORS Semi-auto
Lotrafilcon B contact lens with color, automated, worn first, with Lotrafilcon B contact lens with color, semi-automated, worn second.
Each product worn on a daily wear basis approximately 8 hours a day, 5 days a week, for 2 weeks.
|
Silicone hydrogel contact lens with color manufactured via an automated process
Other Names:
Silicone hydrogel contact lens with color manufactured via a semi-automated process
Other Names:
|
Other: AIR OPTIX® COLORS Semi-auto, then AIR OPTIX® COLORS Auto
Lotrafilcon B contact lens with color, semi-automated, worn first, with Lotrafilcon B contact lens with color, automated, worn second.
Each product worn on a daily wear basis approximately 8 hours a day, 5 days a week, for 2 weeks.
|
Silicone hydrogel contact lens with color manufactured via an automated process
Other Names:
Silicone hydrogel contact lens with color manufactured via a semi-automated process
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Overall satisfaction
Time Frame: Week 2
|
The participant was asked, "Please rate your overall satisfaction based on your experience with the study lenses over the last 2 weeks.
When considering your rating, please take into account comfort, vision, and handling, but disregard the appearance of the lenses."
Overall satisfaction was rated on a scale of 1-10, with 1=Not at all satisfied, and 10=Completely satisfied.
|
Week 2
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Overall lens fit
Time Frame: Dispense (Day 0)
|
Overall lens fit was assessed by the investigator on a 5-point scale, with +2=Unacceptably loose, +1=Acceptably loose, 0=Optimal, -1=Acceptably tight, -2=Unacceptably tight.
|
Dispense (Day 0)
|
Overall lens fit
Time Frame: Week 2
|
Overall lens fit was assessed by the investigator on a 5-point scale, with +2=Unacceptably loose, +1=Acceptably loose, 0=Optimal, -1=Acceptably tight, -2=Unacceptably tight.
|
Week 2
|
Contact Lens Corrected Visual Acuity (CLCVA)
Time Frame: Dispense (Day 0)
|
CLCVA (corrected distance monocular visual measurement in normal illumination) was tested for each eye individually while wearing study lenses.
Participant read a Snellen chart distant to the participant in normal lighting, with 20/20 Snellen acuity considered normal distance eyesight.
|
Dispense (Day 0)
|
Corrected distance monocular visual measurement in normal illumination reported as Contact Lens Corrected Visual Acuity (CLCVA)
Time Frame: Week 2
|
As tested for each eye individually while wearing study lenses.
Participant will read a Snellen chart distant to the participant in normal lighting, with 20/20 Snellen acuity considered normal distance eyesight.
|
Week 2
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Sharon Holden Thomas, O.D., Alcon Research
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2012
Primary Completion (Actual)
August 1, 2012
Study Completion (Actual)
August 1, 2012
Study Registration Dates
First Submitted
June 5, 2012
First Submitted That Met QC Criteria
June 6, 2012
First Posted (Estimate)
June 8, 2012
Study Record Updates
Last Update Posted (Actual)
May 5, 2017
Last Update Submitted That Met QC Criteria
May 3, 2017
Last Verified
February 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P-383-C-005/C-12-026
- C-12-026 (Other Identifier: Alcon)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
He Eye HospitalNot yet recruiting
-
University of BradfordCoopervision, Inc.; University of HuddersfieldNot yet recruiting
-
Visioneering Technologies, IncRecruitingMyopiaUnited States, Canada, Hong Kong, Singapore
-
University Eye Hospital, FreiburgRecruiting
-
Shanghai 10th People's HospitalCompletedMyopia | Myopia, ProgressiveChina
-
Tianjin Eye HospitalActive, not recruiting
-
Tianjin Eye HospitalCompleted
-
Sultan Qaboos UniversityChristian Medical College, Vellore, IndiaUnknown
-
Peking University People's HospitalUnknownProgressive MyopiaChina
-
Shanghai Eye Disease Prevention and Treatment CenterNot yet recruiting
Clinical Trials on Lotrafilcon B contact lens with color, automated
-
CIBA VISIONUniversity of WaterlooCompleted
-
Alcon ResearchCompleted
-
Alcon ResearchCompletedRefractive Error | Myopia
-
CIBA VISIONCompletedCosmetic Appearance
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.Completed
-
CIBA VISIONUniversity of WaterlooCompleted
-
CIBA VISIONCompleted